Aroa Biosurgery investor relations material

Aroa Biosurgery Limited , a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company offers an injectable dermal substitute, dermadoctor; surgical implants and kits, such as Aroabifix Stapleless, AroaBifix Ultra Nail, AroaBifix2 Inlay, AroaBifix2 Thin Mesh, AroaBifix2 Thin Mesh 2-pack; and a wide range of medical supplies for surgical applications in North America. It also provides water soluble reconstructive meshes for use as surgical implant. The company markets its products through direct sales to hospitals, distributors and surgeons through its field sales offices located in 10 cities throughout the United States.